Why should pediatric rheumatology be recognized as a separate subspecialty: an open letter to medical councils and government agencies.
Why should pediatric rheumatology be recognized as a separate subspecialty: an open letter to medical councils and government agencies.
复制标题
DOI：
10.1186/1546-0096-5-21
复制
发表时间：
2007-11-21
期刊：
影响因子：
--
通讯作者：
Spencer, Charles H
中科院分区：
文献类型：
--
作者：
Spencer, Charles H
西方的一些儿科风湿病学家可能理所当然地认为儿科风湿病学 (PR) 是一个公认的亚专业。然而，直到 1990 年，儿科风湿病学才在美国被接受为亚专科。仍有许多国家的许多儿科亚专科没有得到官方认可和支持，包括 PR。这种认识的缺乏延迟并阻碍了 PR 的发展、医学院适当的肌肉骨骼和风湿病教学以及对患有这些疾病的儿童的最佳诊断和治疗。编辑人员认为，每个儿科风湿病学作为亚专科发展相当完善的国家都有义务帮助我们其他地方的儿科风湿病学家获得认可、支持和尊重。欧洲小儿风湿病学会 (PReS) 和小儿风湿病国际试验组织 (PRINTO) 一直是这项工作的领导者，但在许多国家，小儿风湿病仍未得到认可。这篇社论为医疗和政府实体将儿科风湿病学视为一个可能有助于这些努力的独立亚专业提供了理由和理由。
Some pediatric rheumatologists in the West may take for granted that pediatric rheumatology (PR) is a recognized subspecialty. Yet pediatric rheumatology has been accepted as a subspecialty in the United States only since 1990. There are still countries where many pediatric subspecialties are not given official recognition and support, including PR. This lack of recognition delays and impedes the development of PR, appropriate musculoskeletal and rheumatic teaching in medical schools, and optimal diagnosis and treatment for children with these illnesses. In the opinion of editorial staff, each country where pediatric rheumatology is reasonably well developed as a subspecialty has an obligation to help our pediatric rheumatologists elsewhere gain recognition, support, and respect. The Pediatric Rheumatology European Society (PReS) and the Pediatric Rheumatology International Trial Organization (PRINTO) have been leaders in this effort, but in many countries, pediatric rheumatology is still not recognized. This editorial offers rationales and justifications for medical and governmental entities accrediting pediatric rheumatology as a separate subspecialty that may aid in these efforts.